Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A fusion inhibitor (FP-21399) for the treatment of human immunodeficiency virus infection: a phase I study.

A fusion inhibitor (FP-21399) for the treatment of human immunodeficiency virus infection: a phase I study. J Infect Dis. 2000 Aug; 182(2):607-10.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.